These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 351886)

  • 21. Prolongation of canine renal allografts in the immunosuppressed host by donor pretreatment with cytolytic agents.
    McCabe R; Swistel A; Lorieo D; Fitzpatrick HF
    Transplant Proc; 1980 Jun; 12(2):355-7. PubMed ID: 6156529
    [No Abstract]   [Full Text] [Related]  

  • 22. Donor pretreatment in cardiac allografts.
    Nowygrod R; Hardy MA; Todd GJ; Oluwole S; Reemtsma K
    Transplant Proc; 1979 Jun; 11(2):1462-4. PubMed ID: 382540
    [No Abstract]   [Full Text] [Related]  

  • 23. A prospective randomized double-blind controlled study of cadaver donor pretreatment with cyclophosphamide in human renal transplantation.
    Chatterjee SN; Smith R; Fine S; Schulman B; Fine RN
    Transplant Proc; 1981 Mar; 13(1 Pt 2):709-11. PubMed ID: 7022938
    [No Abstract]   [Full Text] [Related]  

  • 24. Improved survival after donor pretreatment with anti-lymphoblast globulin (ALG) in perfused kidneys: experimental findings.
    Toledo-Pereyra LH; Taiyebb S; McKenzie GH; Gordon DA; Sy GS
    J Surg Res; 1981 Aug; 31(2):172-7. PubMed ID: 7022024
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunosuppression and rehabilitation following cadaveric renal transplantation. New developments.
    Guttmann RD; Beaudoin JG; Gonda A; Gorman P
    Urology; 1973 Feb; 1(2):102-7. PubMed ID: 4589225
    [No Abstract]   [Full Text] [Related]  

  • 26. Prolongation of canine renal allograft survival. A study on the effect of donor pretreatment.
    van der Linden CJ; Buurman WA; Vegt PA; Greep JM; Jeekel J
    Transplantation; 1980 Aug; 30(2):132-4. PubMed ID: 7010708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for renal allograft survival from pediatric cadaver donors: an analysis of united network for organ sharing data.
    Bresnahan BA; McBride MA; Cherikh WS; Hariharan S
    Transplantation; 2001 Jul; 72(2):256-61. PubMed ID: 11477349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of transfusions and donor pretreatment on canine renal allograft survival.
    van der Linden CJ; Buurman WA; Vegt PA; Slot HB; Greep JM; Jeekel H
    J Surg Res; 1981 Oct; 31(4):332-6. PubMed ID: 7026900
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of immunologic donor pretreatment on survival of perfused canine renal allografts.
    Pechan W; Novick AC; Stowe N; Magnusson M; Straffon RA
    Invest Urol; 1980 Jul; 18(1):74-6. PubMed ID: 6997225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Improvement of the results of renal transplantation by the use of antilymphocyte globulin (ALG)].
    Renna E; Alfani D; Monari C; Trovati A; Berloco P; Famulari A; Cucchiara G; Cortesini R
    Minerva Chir; 1980 May; 35(10):747-50. PubMed ID: 7005730
    [No Abstract]   [Full Text] [Related]  

  • 31. Recipient lymphocyte sensitivity to methylprednisolone affects cadaver kidney graft survival.
    Langhoff E; Ladefoged J; Jakobsen BK; Platz P; Ryder LP; Svejgaard A; Thaysen JH
    Lancet; 1986 Jun; 1(8493):1296-7. PubMed ID: 2872430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term success with double pediatric cadaver donor renal transplants.
    Schneider JR; Sutherland DE; Simmons RL; Fryd DS; Najarian JS
    Ann Surg; 1983 Apr; 197(4):439-42. PubMed ID: 6338845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved immediate graft function with nifedipine in cyclosporine-treated renal allograft recipients--a randomized prospective study.
    Harper SJ; Moorhouse J; Veitch PS; Bell PR; Horsburgh T; Walls J; Donnelly PK; Feehally J
    Transplantation; 1992 Oct; 54(4):742-3. PubMed ID: 1412770
    [No Abstract]   [Full Text] [Related]  

  • 35. Donor catecholamine use reduces acute allograft rejection and improves graft survival after cadaveric renal transplantation.
    Schnuelle P; Lorenz D; Mueller A; Trede M; Van Der Woude FJ
    Kidney Int; 1999 Aug; 56(2):738-46. PubMed ID: 10432416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developing ways of reducing allograft immunogenicity.
    Guttmann RD
    Can Med Assoc J; 1981 Jan; 124(2):143-5. PubMed ID: 7006782
    [No Abstract]   [Full Text] [Related]  

  • 37. The UNOS renal transplant registry.
    Cecka JM
    Clin Transpl; 2001; ():1-18. PubMed ID: 12211771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry.
    Takemoto S; Terasaki PI; Cecka JM; Cho YW; Gjertson DW
    N Engl J Med; 1992 Sep; 327(12):834-9. PubMed ID: 1508242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The UNOS Scientific Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 1999; ():1-21. PubMed ID: 11038622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of donor pretreatment and low-dose immunosuppression on the 24-hour preserved canine renal allograft.
    Swistel AJ; McCabe RE; Lorieo DR; Wildstein A; Fitzpatrick HF
    Transplant Proc; 1979 Sep; 11(3):1673-5. PubMed ID: 388773
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.